NO983667L - Krystallmodifikasjon av et farmas°ytisk middel - Google Patents

Krystallmodifikasjon av et farmas°ytisk middel

Info

Publication number
NO983667L
NO983667L NO983667A NO983667A NO983667L NO 983667 L NO983667 L NO 983667L NO 983667 A NO983667 A NO 983667A NO 983667 A NO983667 A NO 983667A NO 983667 L NO983667 L NO 983667L
Authority
NO
Norway
Prior art keywords
crystal modification
pharmaceutical surfactant
surfactant
pharmaceutical
crystal
Prior art date
Application number
NO983667A
Other languages
English (en)
Other versions
NO329315B1 (no
NO983667D0 (no
Inventor
Robert Portmann
Urs Christoph Hofmeier
Andreas Burkhard
Walter Scherrer
Martin Szelagiewicz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4209650&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO983667(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO983667D0 publication Critical patent/NO983667D0/no
Publication of NO983667L publication Critical patent/NO983667L/no
Publication of NO329315B1 publication Critical patent/NO329315B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19983667A 1997-06-10 1998-08-11 Krystallmodifikasjon av forbindelse, farmasoytiske preparater inneholdende denne og anvendelse av krystallmodifikasjonen. NO329315B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH140497 1997-06-10
PCT/EP1998/003427 WO1998056772A1 (en) 1997-06-10 1998-06-08 Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3--triazole-4-carboxamide and its use as antiepileptic

Publications (3)

Publication Number Publication Date
NO983667D0 NO983667D0 (no) 1998-08-11
NO983667L true NO983667L (no) 1998-12-17
NO329315B1 NO329315B1 (no) 2010-09-27

Family

ID=4209650

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19983667A NO329315B1 (no) 1997-06-10 1998-08-11 Krystallmodifikasjon av forbindelse, farmasoytiske preparater inneholdende denne og anvendelse av krystallmodifikasjonen.
NO19983666A NO329314B1 (no) 1997-06-10 1998-08-11 Krystallmodifikasjon av et farmasoytisk middel, anvendelse derav samt farmasoytisk preparat inneholdende krystallmodifikasjonen.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO19983666A NO329314B1 (no) 1997-06-10 1998-08-11 Krystallmodifikasjon av et farmasoytisk middel, anvendelse derav samt farmasoytisk preparat inneholdende krystallmodifikasjonen.

Country Status (36)

Country Link
US (6) US6740669B1 (no)
EP (2) EP0994864B1 (no)
JP (2) JP3672574B2 (no)
KR (2) KR100409168B1 (no)
CN (3) CN1159300C (no)
AR (4) AR012945A1 (no)
AT (2) ATE237599T1 (no)
AU (2) AU725517B2 (no)
BR (2) BR9804946A (no)
CA (3) CA2256015C (no)
CO (2) CO4940448A1 (no)
CY (1) CY2007014I2 (no)
CZ (2) CZ292481B6 (no)
DE (3) DE122007000051I2 (no)
DK (2) DK0994863T3 (no)
ES (2) ES2197485T3 (no)
FR (1) FR07C0037I2 (no)
HU (2) HU226107B1 (no)
ID (2) ID27660A (no)
IL (2) IL125732A (no)
LU (1) LU91345I2 (no)
MY (2) MY120156A (no)
NL (1) NL300284I2 (no)
NO (2) NO329315B1 (no)
NZ (2) NZ331371A (no)
PE (2) PE79799A1 (no)
PL (2) PL191943B1 (no)
PT (1) PT994864E (no)
RU (2) RU2194041C2 (no)
SI (2) SI0994864T1 (no)
SK (2) SK283685B6 (no)
TR (2) TR199801630T1 (no)
TW (2) TW526195B (no)
UY (1) UY25844A1 (no)
WO (2) WO1998056772A1 (no)
ZA (2) ZA984967B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW526195B (en) * 1997-06-10 2003-04-01 Novartis Ag Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and their use
US7192962B2 (en) * 2002-05-31 2007-03-20 Schering Corporation Xanthine phosphodiesterase V inhibitor polymorphs
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US7875284B2 (en) * 2006-03-10 2011-01-25 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
US20090069390A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched rufinamide
US8183269B2 (en) 2008-10-13 2012-05-22 Cipla Limited Process for the preparation of rufinamide
CN101768124B (zh) * 2008-12-30 2012-01-04 北京本草天源药物研究院 一种药物晶体及其制备方法和用途
IT1395736B1 (it) * 2009-08-04 2012-10-19 Dipharma Francis Srl Forme cristalline di rufinamide
CA2772075C (en) * 2009-09-04 2017-02-28 Rashida A. Karmali Novel compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations
WO2011135105A1 (en) 2010-04-30 2011-11-03 Laboratorios Lesvi, S.L. Improved process for preparing rufinamide intermediate
EP2465853A1 (en) * 2010-12-14 2012-06-20 Laboratorios Lesvi, S.L. Polymorph of rufinamide and process for obtaining it
ITMI20110718A1 (it) 2011-04-29 2012-10-30 Dipharma Francis Srl Procedimento per la purificazione di rufinamide
WO2014013511A2 (en) * 2012-07-20 2014-01-23 Hetero Research Foundation Rufinamide solid dispersion
WO2021099481A1 (en) 2019-11-20 2021-05-27 Medichem, S.A. Solid composition containing rufinamide

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992378A (en) 1973-12-26 1976-11-16 Eli Lilly And Company Fluoralkyl quinoxadinediones
US4156734A (en) * 1976-02-13 1979-05-29 Merck & Co., Inc. Antihypertensive compositions containing an aryl-substituted alanine azo and an arylhydrazino-propionic acid
GB1511195A (en) 1976-10-18 1978-05-17 Ici America Inc Triazole derivatives
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4346097A (en) * 1980-09-30 1982-08-24 Warner-Lambert Company Method for treating convulsions with pyrazole-4-carboxamide derivatives
FI834666A7 (fi) 1982-12-23 1984-06-24 Ciba Geigy Ag Foerfarande foer framstaellning av nya aralkyltriazolfoereningar.
US4789680A (en) * 1982-12-23 1988-12-06 Ciba-Geigy Corporation Aralkyltriazole compounds
US4511572A (en) * 1983-03-18 1985-04-16 The University Of Kentucky Research Foundation Triazoline anticonvulsant drugs
FI93544C (fi) * 1985-04-18 1995-04-25 Ciba Geigy Ag Menetelmä fluorattujen, antikonvulsiivisesti vaikuttavien 1-bentsyyli-1H-1,2,3-triatsoliyhdisteiden valmistamiseksi
CA2002864C (en) 1988-11-29 1999-11-16 Eddy J. E. Freyne (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
JPH02214504A (ja) 1989-02-15 1990-08-27 Nissan Chem Ind Ltd 光学活性キノキサリン化合物の晶析法
JPH04506967A (ja) 1989-07-27 1992-12-03 ジー．ディー．サール　アンド　カンパニー 高血圧症治療用腎選択性生成物
IL96507A0 (en) 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
ATE194985T1 (de) 1990-11-06 2000-08-15 Yamanouchi Pharma Co Ltd Kondensiertes pyrazinderivat
JP2753911B2 (ja) 1991-12-06 1998-05-20 キッセイ薬品工業株式会社 Ｎ−ｔｅｒｔ−ブチル−１−メチル−３，３−ジフェニルプロピルアミン塩酸塩の結晶多形およびその製造方法
DE4217952A1 (de) 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5631373A (en) 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
GB9418443D0 (en) 1994-09-13 1994-11-02 Pfizer Ltd Therapeutic agents
GB9419318D0 (en) 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents
CN1072215C (zh) 1995-02-22 2001-10-03 赫彻斯特药品和化学品公司 无定形吡咯他尼、吡咯他尼多晶型物,其制备方法和用途
ATE216990T1 (de) * 1996-07-11 2002-05-15 Novartis Ag Verfahren zur herstellung von 1-substituierten 4- cyan-1,2,3-triazolen
TW526195B (en) * 1997-06-10 2003-04-01 Novartis Ag Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and their use

Also Published As

Publication number Publication date
NO329314B1 (no) 2010-09-27
ATE232852T1 (de) 2003-03-15
BR9804947A (pt) 1999-08-24
DK0994864T3 (da) 2003-07-21
HUP0000798A2 (hu) 2000-10-30
CA2614926C (en) 2010-02-09
HUP0000798A3 (en) 2000-10-30
SI0994863T1 (en) 2003-08-31
US20100310655A1 (en) 2010-12-09
BR9804946A (pt) 1999-08-24
PL330764A1 (en) 1999-05-24
ZA984967B (en) 1999-01-11
US8076362B2 (en) 2011-12-13
NO329315B1 (no) 2010-09-27
DE69813560T2 (de) 2004-02-05
AR012946A1 (es) 2000-11-22
CZ292481B6 (cs) 2003-09-17
CA2256015A1 (en) 1998-12-17
TW403740B (en) 2000-09-01
NZ331370A (en) 2000-08-25
MY120156A (en) 2005-09-30
EP0994864B1 (en) 2003-04-16
HK1028241A1 (en) 2001-02-09
DE69811500T2 (de) 2004-04-01
US7750028B2 (en) 2010-07-06
NL300284I2 (nl) 2007-11-01
PT994864E (pt) 2003-07-31
CN1259127A (zh) 2000-07-05
WO1998056772A1 (en) 1998-12-17
TR199801631T1 (xx) 1999-06-21
IL125732A (en) 2002-12-01
HU226107B1 (en) 2008-04-28
ES2197485T3 (es) 2004-01-01
JP2000516258A (ja) 2000-12-05
CN1572789A (zh) 2005-02-02
PL192114B1 (pl) 2006-08-31
MY125854A (en) 2006-08-30
CY2007014I1 (el) 2009-11-04
DE69811500D1 (de) 2003-03-27
AR061005A2 (es) 2008-07-30
CO4940452A1 (es) 2000-07-24
PL191943B1 (pl) 2006-07-31
CN1132820C (zh) 2003-12-31
JP3672574B2 (ja) 2005-07-20
CZ253498A3 (cs) 1999-04-14
CA2256013A1 (en) 1998-12-17
NO983666L (no) 1998-12-17
SK109398A3 (en) 1998-12-02
UY25844A1 (es) 2001-08-27
RU2194041C2 (ru) 2002-12-10
JP2000516259A (ja) 2000-12-05
CA2256013C (en) 2007-10-16
ZA984966B (en) 1999-01-11
RU2198167C2 (ru) 2003-02-10
LU91345I2 (fr) 2007-09-04
KR100425656B1 (ko) 2004-05-17
NL300284I1 (nl) 2007-10-01
NO983667D0 (no) 1998-08-11
ATE237599T1 (de) 2003-05-15
KR19990087835A (ko) 1999-12-27
US20040167186A1 (en) 2004-08-26
AU8437198A (en) 1998-12-30
CN1159300C (zh) 2004-07-28
FR07C0037I1 (no) 2007-08-17
CN1298708C (zh) 2007-02-07
CA2256015C (en) 2008-06-03
NZ331371A (en) 2000-08-25
NO983666D0 (no) 1998-08-11
US20010037029A1 (en) 2001-11-01
HUP0002113A2 (hu) 2001-02-28
CZ292260B6 (cs) 2003-08-13
CA2614926A1 (en) 1998-12-17
IL125733A0 (en) 1999-04-11
DK0994863T3 (da) 2003-05-26
AR012945A1 (es) 2000-11-22
DE122007000051I2 (de) 2009-02-19
PE79799A1 (es) 1999-09-03
CN1217716A (zh) 1999-05-26
CO4940448A1 (es) 2000-07-24
AU8437298A (en) 1998-12-30
CY2007014I2 (el) 2009-11-04
PE80999A1 (es) 1999-09-06
SI0994864T1 (en) 2003-10-31
US20060116520A1 (en) 2006-06-01
LU91345I9 (no) 2018-12-31
AU725528B2 (en) 2000-10-12
ID21014A (id) 1999-04-08
AR061004A2 (es) 2008-07-30
US20030125568A1 (en) 2003-07-03
TR199801630T1 (xx) 1999-06-21
ID27660A (id) 2001-04-19
CZ253398A3 (cs) 1999-04-14
SK109498A3 (en) 1998-12-02
KR19990087836A (ko) 1999-12-27
DE122007000051I1 (de) 2007-11-08
PL330798A1 (en) 1999-06-07
TW526195B (en) 2003-04-01
EP0994863A1 (en) 2000-04-26
ES2192779T3 (es) 2003-10-16
AU725517B2 (en) 2000-10-12
IL125732A0 (en) 1999-04-11
US6740669B1 (en) 2004-05-25
IL125733A (en) 2002-12-01
EP0994864A1 (en) 2000-04-26
HK1028031A1 (en) 2001-02-02
HK1028242A1 (en) 2001-02-09
HU225153B1 (en) 2006-07-28
SK283734B6 (sk) 2003-12-02
WO1998056773A1 (en) 1998-12-17
KR100409168B1 (ko) 2004-01-31
FR07C0037I2 (no) 2008-05-16
EP0994863B1 (en) 2003-02-19
SK283685B6 (sk) 2003-12-02
HUP0002113A3 (en) 2002-09-30
DE69813560D1 (de) 2003-05-22
JP3672575B2 (ja) 2005-07-20
US6455556B2 (en) 2002-09-24

Similar Documents

Publication Publication Date Title
DE69826244D1 (de) Programmierbarer kristalloszillator
NO331016B1 (no) Krystallmodifikasjon av et N-fenyl-2-pyrimidinaminderivat
ID29306A (id) Bentuk baru s-omeprazola
FI972292A0 (fi) Administrering av diabetes
IS5245A (is) Lyfjablanda úr ómeprasól
DE122010000011I1 (de) Flüssige gonadotropinhaltige Arzneimittel
ATE239481T1 (de) Filmueberzogene tabletten von oxacarbazepin
ID24247A (id) Penjajaran cetakan tunggal
ID23874A (id) Obat
PT1163244E (pt) Compostos de tienopirimidina sua producao e sua utilizacao
NO983666L (no) Krystallmodifikasjon av et farmas°ytisk middel
DK1017392T3 (da) Lægemiddel
ID27996A (id) Polimorf dari suatu bahan farmasi
ID22589A (id) Piranti tampilan yang dapat diprogram
DE69800559D1 (de) Ferrielektrische Flüssigkristallverbindung
FI956178A0 (fi) Varsibromelaiiniproteaasin lääkekäyttö
NO20010782D0 (no) Krystalloscillator
DK1041966T3 (da) Farmaceutiske præparater omfattende zafirlukast
FI973519A7 (fi) 4-aminotetrahydrobentsioksatsoli- ja -isotiatsoliyhdisteitä
DE69823908D1 (de) Einkristallziehvorrichtung
ID28451A (id) Trisiklik piperidin-δ3 sebagai bahan farmasi
ID24327A (id) Produksi senyawa-senyawa avermektin
ID18156A (id) Produk farmasi kristal
EE200000401A (et) Farmatseutilise preparaadi valmistamismeetod
DE69803309D1 (de) Rückgewinnung von gipsmaterialien

Legal Events

Date Code Title Description
MK1K Patent expired